They only missed by a penny on earnings but were extremely conservative in forward guidance for the rest of 2010, assuming no earnings from Vivimo (it's already in some pharmacies) and no Euro approval in 2010 either (another $25 mil milestone payment).
If their dour outlook comes true it's dead money for another 6 months.....
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.